TreeFrog Therapeutics - Cell Therapy for All - 2021 - Video

Incorporated in Bordeaux, France, in 2018, TreeFrog Therapeutics aims to provide access to safe and affordable cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem™, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem cells in industrial bioreactors. Currently expanding in the US and Japan, TreeFrog is advancing a pipeline of cell therapies targeting neurodegenerative diseases, cardiac and metabolic disorders, as well as blood and immune-related diseases.